■論説
がん医療と緩和ケア（7）―終末期がん患者における輸液治療の現状とQOL指標
杉山 未緒, 伊勢 雄也, 片山 志郎
日本医科大学付属病院薬剤部
Recent Reports on Fluid Therapy for Terminally Ill Cancer Patients and Indicators of Quality of Life
Mio Sugiyama, Yuya Ise and Shirou Katayama
Department of Pharmaceutical Service, Nippon Medical School Hospital
Terminal cancer patients gradually reduce their oral intake, which can lead to cachexia and metabolic abnormalities. According to Japanese Society of Palliative Medicine guidelines, patients should reduce their fluid intake from one month before projected death. The effectiveness of fluid therapy in these patients should be evaluated by assessing their quality of life (QOL), and not only on the basis of physical symptoms. However, no specific QOL indicators are set out in the guidelines. We have reviewed recent reports on fluid therapy in terminally ill cancer patient in an attempt to identify appropriate indicators of QOL in palliative medicine.
日医大医会誌 2015; 11(3), 145-150
Key words
terminally ill, cancer, fluid therapy, quality of life, guidelines
Correspondence to
Mio Sugiyama, Department of Pharmaceutical Service, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
E-mail：miosugi@nms.ac.jp
受付：2015年1月8日 受理：2015年6月4日 |
全文PDF